Guardian Pharmacy Services Income Statement (2023-2026) | GRDN

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 262.74M281.07M275.41M300.04M314.39M338.57M329.31M344.33M377.43M397.62M336.60M
Cost of Revenue (Quarter) 210.55M226.49M220.31M238.75M253.51M271.46M264.96M276.19M302.71M312.11M260.29M
Gross Profit (Quarter) 52.19M54.58M55.10M61.29M60.88M67.10M64.35M68.15M74.72M85.50M76.31M
Operating items
Selling, General & Administrative (Quarter) 58.52M39.05M47.17M44.28M165.49M50.35M51.34M55.57M58.37M54.74M58.63M
Operating Expenses (Quarter) 58.52M39.05M47.17M44.28M165.49M50.35M51.34M55.57M58.37M54.74M58.63M
Operating Income (Quarter) -6.33M15.52M7.93M17.00M-104.61M16.75M13.01M12.58M16.35M30.76M17.68M
EBIT (Quarter) -6.33M15.52M7.93M17.00M-104.61M16.75M13.01M12.58M16.35M30.76M17.68M
Non-operating items
Other Non Operating Income (Quarter) 0.05M-0.23M-0.07M-0.09M-0.00M-0.11M0.27M0.18M0.44M0.50M0.77M
Non Operating Income (Quarter) -0.67M-0.23M-0.07M-0.09M-1.03M-0.53M0.27M0.01M0.28M1.00M0.77M
Net income details
EBT (Quarter) -7.00M14.56M7.09M15.85M-105.64M16.22M13.11M12.59M16.63M31.10M18.29M
Tax Provisions (Quarter) 0.18M4.38M3.83M3.76M7.04M9.83M4.75M
Profit After Tax (Quarter) -7.00M14.56M7.09M15.85M-121.99M-27.17M9.27M9.03M9.59M21.53M13.54M
Income from Non-Controlling Interests (Quarter) 4.29M2.54M4.31M5.22M6.82M-0.10M-0.17M-0.20M-0.23M0.34M0.25M
Income from Continuing Operations (Quarter) -7.00M14.56M7.09M15.85M-105.82M11.84M9.27M8.83M9.59M21.27M13.54M
Consolidated Net Income (Quarter) -7.00M14.56M7.09M15.85M-105.82M11.84M9.27M8.83M9.59M21.27M13.54M
Income towards Parent Company (Quarter) -7.00M14.56M7.09M15.85M-105.82M11.84M9.27M8.83M9.59M21.27M13.54M
Net Income towards Common Stockholders (Quarter) -7.00M14.56M7.09M15.85M-105.82M11.84M9.27M8.83M9.59M21.27M13.54M
Additional items
EPS (Basic) (Quarter) -2.000.230.150.150.160.330.21
EPS (Weighted Average and Diluted) (Quarter) -2.000.230.150.140.150.330.21
Shares Outstanding (Weighted Average) (Quarter) 8.30M9.16M0.05M22.41M23.02M62.39M0.06M
Shares Outstanding (Diluted Average) (Quarter) 8.30M62.01M0.06M63.20M63.18M63.30M0.04M
EBITDA (Quarter) -6.33M15.52M7.93M17.00M-104.61M16.75M13.01M12.58M16.35M30.76M17.68M
Interest Expenses (Quarter) 0.72M0.74M0.77M1.07M1.03M0.42M0.17M0.17M0.16M0.16M0.15M
Tax Rate (Quarter) -0.17%27.00%29.25%29.87%42.32%31.62%25.96%